Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Cornea and External Disease
When should mitomycin intravascular chemoembolization be considered as a treatment for corneal neovascularization?
Related Questions
When do you consider performing laser refractive surgery on corneal transplants?
How would you approach the management of a patient presenting with bilateral central corneal perforations following treatment with Ipilimumab/Nivolumab?
How do you approach IOL calculations and selection in patients with keratoconus based on disease severity?
What is your approach to incorporating IPL therapy for meibomian gland dysfunction?
What factors should be considered when deciding whether to perform corneal crosslinking (CXL) in mild cases of keratoconus?
What has been your experience with netarsudil in the management of corneal edema, particularly concerning its clinical effectiveness and insurance coverage?
How do you determine the role of adjunctive therapies for a patient with conjunctival squamous cell carcinoma (SCC) that has recurred after initial surgical excision?
How do you manage corneal ectasia after refractive surgery?
What is the best course of treatment for limbal stem cell deficiency with a perforated corneal ulcer?
How do you determine whether to proceed with topography-guided PRK, lamellar keratoplasty, or a full-thickness transplant in patients with irregular astigmatism and corneal scarring?
